SYNAPTICS Inc — Director's Dealing 2021

Feb 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2021-02-08

Reporting Person: McFarland John (SVP, General Counsel & Sec.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-08	Common Stock	M	3000	$79.38	Acquired	17860	Direct
2021-02-08	Common Stock	M	2725	$89.29	Acquired	20585	Direct
2021-02-08	Common Stock	M	3000	$76.81	Acquired	23585	Direct
2021-02-08	Common Stock	M	3000	$85.69	Acquired	26585	Direct
2021-02-08	Common Stock	M	2725	$73.31	Acquired	29310	Direct
2021-02-08	Common Stock	M	2725	$71.55	Acquired	32035	Direct
2021-02-08	Common Stock	S	3100	$117.4691	Disposed	28935	Direct
2021-02-08	Common Stock	S	8190	$118.6601	Disposed	20745	Direct
2021-02-08	Common Stock	S	1674	$120.4336	Disposed	19071	Direct
2021-02-08	Common Stock	S	4211	$121.4666	Disposed	14860	Direct
2021-02-09	Common Stock	M	2725	$51.95	Acquired	17585	Direct
2021-02-09	Common Stock	M	3575	$52.57	Acquired	21160	Direct
2021-02-09	Common Stock	M	3575	$54.36	Acquired	24735	Direct
2021-02-09	Common Stock	M	3575	$54.77	Acquired	28310	Direct
2021-02-09	Common Stock	S	1400	$121.4081	Disposed	26910	Direct
2021-02-09	Common Stock	S	4328	$122.591	Disposed	22582	Direct
2021-02-09	Common Stock	S	7722	$123.0166	Disposed	14860	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-08	Employee Stock Option (Right to Buy)	$79.38	M	3000	Disposed	2022-07-31	Common Stock (3000)	Direct
2021-02-08	Employee Stock Option (Right to Buy)	$89.29	M	2725	Disposed	2022-10-23	Common Stock (2725)	Direct
2021-02-08	Employee Stock Option (Right to Buy)	$76.81	M	3000	Disposed	2022-01-30	Common Stock (3000)	Direct
2021-02-08	Employee Stock Option (Right to Buy)	$85.69	M	3000	Disposed	2022-04-24	Common Stock (3000)	Direct
2021-02-08	Employee Stock Option (Right to Buy)	$73.31	M	2725	Disposed	2023-01-29	Common Stock (2725)	Direct
2021-02-08	Employee Stock Option (Right to Buy)	$71.55	M	2725	Disposed	2023-04-29	Common Stock (2725)	Direct
2021-02-09	Employee Stock Option (Right to Buy)	$51.95	M	2725	Disposed	2023-07-29	Common Stock (2725)	Direct
2021-02-09	Employee Stock Option (Right to Buy)	$52.57	M	3575	Disposed	2023-10-28	Common Stock (3575)	Direct
2021-02-09	Employee Stock Option (Right to Buy)	$54.36	M	3575	Disposed	2024-01-27	Common Stock (3575)	Direct
2021-02-09	Employee Stock Option (Right to Buy)	$54.77	M	3575	Disposed	2024-04-28	Common Stock (3575)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.92 to $117.79,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118 to $118.94,
inclusive. The reporting person undertakes to provide to Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.92 to $120.79,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.928 to $121.740, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.95 to $121.91,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122 to $122.96,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123 to $123.14,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F8: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 31, 2015 date of grant, until fully vested on July 31, 2018.

F9: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.

F10: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018.

F11: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018.

F12: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 29, 2016 date of grant, until fully vested on January 29, 2019.

F13: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 29, 2016 date of grant, until fully vested on April 29, 2019.

F14: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 29, 2016 date of grant, until fully vested on July 29, 2019.

F15: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of October 28, 2016, with the remaining 2/3rds vesting quarterly until fully vested on October 28, 2019.

F16: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of January 27, 2017,with the remaining 2/3rds vesting quarterly until fully vested on January 27, 2020.

F17: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of April 28, 2017, with the remaining 2/3rds vesting quarterly until fully vested on April 28, 2020.